세계의 유도만능줄기세포(iPSC) : 시장

The global market for induced pluripotent stem cells (iPSCs) is expected to grow from $3.4 billion in 2023 to reach $5.2 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.1% from 2023 to 2028.

The global market for iPSCs generated by non-integrated method is expected to grow from $2.1 billion in 2023 to reach $3.4 billion by 2028, at a CAGR of 10.1% from 2023 to 2028.

The global market for iPSCs generated by integrated method is expected to grow from $1.3 billion in 2023 to reach $1.8 billion by 2028, at a CAGR of 7.5% from 2023 to 2028.

Report Scope

The scope of this study encompasses an investigation of the market. BCC Research analyzes this market based on application type, product function, generation of iPSC and types of iPSC derived cells and species. Application-based market segments include drug development and toxicity testing, academic research and regenerative medicine. Product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis. iPSC-derived cell-type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells and other cell types. Other cell types include astrocytes, fibroblasts and hematopoietic progenitor cells. BCC Research determines the current market status in each segment, examines its impact on future needs and presents growth forecasts through 2028.

The report also provides a detailed analysis of the market's drivers, restraints, challenges and opportunities. In addition, the report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. it also provides detailed information on this market, emerging technologies and new developments, regulatory landscape, patent analysis, pipeline analysis and investment outlook and deals.

Report Includes

• 28 data tables and 56 additional tables
• An analysis of the global market for induced pluripotent stem cells (iPSCs) or artificial stem cells
• Analyses of global market trends, with market revenue data from 2020 to 2023, and projected CAGRs through 2028
• Estimate of the size and revenue prospects of the global market, along with a market share analysis by reprogramming method, generation method, application, product function, iPSC-derived cell type, species, end use, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the macroeconomic factors that influence the industry
• A Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Insights into iPSC research activity, emerging technologies, clinical trials and pipeline products
• Patent activity and analysis of recent patent grants/publications
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
• Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
• Profiles of market leaders, including Fujifilm Cellular Dynamics (FCDI) Inc., Axol Bioscience Ltd., Merck KGaA, Thermo Fisher Scientific Inc., and Takara Bio Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Introduction
• Induced Pluripotent Stem Cells (iPSC) Generation

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Increasing Prevalence of Chronic Diseases
• Increasing Investment in Biotechnology Industry
• Increasing Demand for Personalized Medicines
• Increasing Investments for Drug Research and Development
• Demand for Effective Drug Discovery and Development Process
• Minimizing Animal Testing
• Market Restraints
• High Development Costs and Lack of Skilled Workforce
• Challenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug Discovery
• Market Opportunities
• Technological Advances
• Growth in iPSC Banking

Chapter 4 Emerging Technologies and Developments

• Advances in the iPSC Research
• Reprogramming Technologies
• Gene Editing Technologies
• 3D Organoids
• Regenerative Medicine
• Evolution and Current Application of Artificial Intelligence (AI) in iPSC Research

Chapter 5 Clinical Trial Analysis

• Clinical Trials

Chapter 6 Patent Analysis

• Patent Analysis

Chapter 7 Market Segmentation Analysis

• Segmentation Breakdown
• Overview
• Generation of Induced Pluripotent Stem Cells -- Market Analysis, by Reprogramming Method
• Market for Induced Pluripotent Stem Cells, by Generation Method
• Market for Induced Pluripotent Stem Cells, by Application
• Academic Research
• Pharmaco-toxicological Screening
• Drug Discovery and Development
• Disease Modeling
• Tissue Engineering
• Cell Therapy
• Global Market
• Regional Markets for iPSCs, by Application
• iPSC-derived Tissue Cell Market, by Type
• Cardiomyocytes
• Neurons
• Endothelial Cells
• Hepatocytes
• Other Cells
• iPSC-derived Tissue Cell Market, by Species
• Global Market
• iPSC-derived Tissue Cell Market, by Application
• Global Market
• Market for Induced Pluripotent Stem Cells, by Product Function
• Global Market
• Regional Markets for iPSCs, by Product Function
• Market for Induced Pluripotent Stem Cells, by End Use
• Induced Pluripotent Stem Cell Contract Service Types
• Major Players
• Global Market
• Geographic Breakdown
• Market for Induced Pluripotent Stem Cells, by Region
• The U.S.
• Europe
• Asia-Pacific
• Rest of the World

Chapter 8 Competitive Intelligence

• Competitive Landscape -- Overview
• Strategic Analysis
• Agreements
• Collaborations & Strategic Alliances
• Partnerships
• New Product Development and Launches
• Expansions and Acquisitions
• Fund Raising
• Approval and Clinical Trials
• Others
• Major Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings

Chapter 9 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ATCC
• AXOL BIOSCIENCE LTD.
• BIO-TECHNE
• FUJIFILM CELLULAR DYNAMICS INC.
• LONZA
• MERCK KGAA
• NCARDIA
• QIAGEN
• REPROCELL INC.
• STEMCELL TECHNOLOGIES
• TAKARA BIO INC.
• THERMO FISHER SCIENTIFIC INC.